Ajanta Pharma Ltd share price logo

Ajanta Pharma Ltd Share Price

NSE: AJANTPHARM

BSE: 532331

Small Cap

Healthcare Sector

₹2548.40

-12.50

(-0.49%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Ajanta Pharma Ltd Stock Performance

as on September 18, 2025 at 4:01 pm IST

  • Day's Low

    Day's High

    ₹2,542
    ₹2,566
    downward going graph

    0.25%

    Downside

    0.69%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹2,327.3
    ₹3,428
    downward going graph

    8.68%

    Downside

    34.52%

    Upside

    downward going graph

Ajanta Pharma Ltd share price movements today

Previous Close
₹2,560.90
Open
₹2,561.00
Volume
45.62K
Upper Circuit
₹3,073.00
Lower Circuit
₹2,048.80
Day's Low - High
₹2,542 - ₹2,566
52 Week Low - High
₹2,327.3 - ₹3,428

Ajanta Pharma Ltd Historical Returns

1 Month Return
-4.83 %
3 Month Return
-0.79 %
1 Year Return
-17.95 %
3 Year Return
+ 102.09 %
5 Year Return
+ 138.13 %

Ajanta Pharma Ltd Fundamentals

as on September 18, 2025 at 4:01 pm IST

Market Cap

₹31,994.76 Cr

Return on Equity (ROE)

26.05

PE Ratio (TTM)

34.46

Return on capital employed (ROCE)

32.78

Industry PE ratio

42.21

Beta (LTM)

0.66

P/B Ratio

9.05

Dividend Yield

1.07

PEG Ratio

5.32

Quarterly Earnings Growth YOY

3.89

EPS (TTM)

73.43

Sector

Pharmaceuticals

Book Value

302.38

Technical Analysis

Bearish

View Technical Analysis

Ajanta Pharma Ltd Stock Valuation

as on September 18, 2025 at 4:01 pm IST

Ajanta Pharma Ltd in the last 5 years

  • Overview

  • Trends

Lowest (17.12x)

June 6, 2018

Today (34.46x)

September 17, 2025

Industry (42.21x)

September 17, 2025

Highest (50.52x)

September 10, 2024

LowHigh

Today’s Price to Earnings Ratio: 34.46x

Ajanta Pharma Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Ajanta Pharma Ltd with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Ajanta Pharma Ltd image
Ajanta Pharma Ltd
BUY31,994.7627.63%0.529204,648
Sanofi India Ltd image
Sanofi India Ltd
BUY11,633.60-8.08%0.524132,013
Aurobindo Pharma Ltd image
Aurobindo Pharma Ltd
BUY64,201.296.46%0.603,48331,723
Zydus Lifesciences Ltd image
Zydus Lifesciences Ltd
HOLD1,04,024.4730.47%0.614,61423,241
Abbott India Ltd image
Abbott India Ltd
BUY65,811.2517.53%0.001,4146,445
See all

Analyst Recommendation on Ajanta Pharma Ltd Stock

Based on 12 analysts

BUY

75.00%

Buy

8.33%

Hold

16.67%

Sell

Based on 12 analysts, 75% of analysts recommend a 'BUY' rating for Ajanta Pharma Ltd. Average target price of ₹3008.33

Source: S&P Global Market Intelligence

Ajanta Pharma Ltd Share Price Target

Get share price movements and forecasts by analysts on Ajanta Pharma Ltd.

What analysts predicted

17.47%UPSIDE

Target Price

₹3008.33

Current Price

₹2548.4

Analyzed by

12 Analysts

High

₹3293

Target

₹3008.33

Low

₹2307

Ajanta Pharma Ltd target price ₹3008.33, a slight upside of 17.47% compared to current price of ₹2548.4. According to 12 analysts rating.

Source: S&P Global Market Intelligence

Ajanta Pharma Ltd Stock's Interest Amongst Investors

Search interest for Ajanta Pharma Ltd Stock has decreased by -17% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-17% versus previous 30 day period

Ajanta Pharma Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Sep 2022
Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sales
938.1
971.77
881.84
1,021.04
1,028.44
1,105.15
1,054.08
1,144.92
1,186.64
1,146.13
1,170.41
1,302.65
Other Income
40.35
34.93
36.83
31.75
21.33
13.59
35.5
26.47
19.48
30.44
18.11
26.33
Total Income
978.45
1,006.7
918.67
1,052.79
1,049.77
1,118.74
1,089.58
1,171.39
1,206.12
1,176.57
1,188.52
1,328.98
Expenses
741.76
802.22
732.47
749.72
737.78
791.08
775.76
814.57
875.47
825.3
873.26
951.3
Operating Profit
196.34
169.55
149.37
271.32
290.66
314.07
278.32
330.35
311.17
320.83
297.15
351.35
Operating Profit Margin %
20.93%
17.45%
16.94%
26.57%
28.26%
28.42%
26.4%
28.85%
26.22%
27.99%
25.39%
26.97%
Profit Before Interest, Tax and Depreciation
236.69
204.48
186.2
303.07
311.99
327.66
313.82
356.82
330.65
351.27
315.26
377.68
Interest
0.99
2.84
1.13
0.85
2.34
2.49
1.53
0.73
6.02
7.91
6.07
5.26
Depreciation
32.7
33.3
33.02
33.18
33.71
34.26
34.25
33.97
34.39
35.97
39.78
41.29
Profit Before Tax
203
168.34
152.05
269.04
275.94
290.91
278.04
322.12
290.24
307.39
269.41
331.13
Tax Paid
46.4
33.83
29.8
60.92
80.64
80.88
75.32
76.35
73.76
74.51
44.15
75.79
Profit After Tax
156.6
134.51
122.25
208.12
195.3
210.03
202.72
245.77
216.48
232.88
225.26
255.34
Total Net profit including share of profit / Loss from associate company
156.6
134.51
122.25
208.12
195.3
210.03
202.72
245.77
216.48
232.88
225.26
255.34
EPS
12.22
10.5
9.54
16.53
15.51
16.68
16.1
19.54
17.27
18.6
18
20.44
Actual EPS
12.22
10.5
9.54
16.53
15.51
16.68
16.1
19.54
17.27
18.6
18
20.44
Adjusted EPS
12.22
10.5
9.54
16.53
15.51
16.68
16.1
19.54
17.27
18.6
18
20.44
Diluted EPS
12.22
10.5
9.54
16.53
15.5
16.67
16.09
19.53
17.26
18.59
18
20.43

Ajanta Pharma Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
2,001.64
2,130.86
2,055.37
2,587.87
2,889.69
3,340.99
3,742.64
4,208.71
4,648.1
Other Income
23.86
24.16
21.08
92.19
25.98
115.68
98.64
84.6
94.5
Total Income
2,025.5
2,155.02
2,076.45
2,680.06
2,915.67
3,456.67
3,841.28
4,293.31
4,742.6
Expenses
1,314.76
1,472.47
1,488.94
1,908.46
1,891.13
2,411.69
2,959.39
3,036.77
3,388.6
Operating Profit
686.88
658.39
566.43
679.41
998.56
929.3
783.25
1,171.94
1,259.5
Operating Profit Margin %
34.32%
30.9%
27.56%
26.25%
34.56%
27.82%
20.93%
27.85%
27.1%
Profit Before Interest, Tax and Depreciation
710.74
682.55
587.51
771.6
1,024.54
1,044.98
881.89
1,256.54
1,354
Interest
1.36
0.41
1.16
11.91
8.27
10.2
5.84
7.21
20.73
Depreciation
61.21
59.59
72.08
95.72
116.09
125.3
130.8
135.4
144.11
Profit Before Tax
648.17
622.55
514.27
663.97
900.18
909.48
745.25
1,113.93
1,189.16
Tax Paid
141.34
153.91
127.3
196.27
246.31
196.8
157.27
297.76
268.77
Profit After Tax
506.83
468.64
386.97
467.7
653.87
712.68
587.98
816.17
920.39
Total Net profit including share of profit / Loss from associate company
506.83
468.64
386.97
467.7
653.87
712.68
587.98
816.17
920.39
EPS
57.59
53.26
43.97
53.6
75.09
54.97
49.89
64.82
73.56
Actual EPS
57.59
53.26
43.97
53.6
75.09
54.97
49.89
64.82
73.56
Adjusted EPS
38.39
35.51
29.31
35.73
50.06
36.65
49.89
64.82
73.56
Diluted EPS
57.58
53.25
43.96
53.6
75.09
54.96
45.89
64.77
73.33

Ajanta Pharma Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
326.15
609.29
281.12
374.51
456.77
576.31
561.71
792.11
785.07
1,157.23
Cash Flow from Investing Activities
88.86
-84.01
6.6
120.19
15.02
-110.77
74.74
-385.11
217.8
-58.6
Cash Flow from Financing Activities
-117.32
-201.77
-0.2
-147.46
-128.63
-318.29
-459.71
-108.2
-1,051.06
-733.41
Net Cash Flow
-0.23
24.4
24.81
4.27
103.74
-24.36
27.9
124.31
-200.6
47.3

Ajanta Pharma Ltd Stock Shareholding Pattern

Numbers in percentages

Dec 2022
Mar 2023
Apr 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Promoters
66.11%
66.11%
66.21%
66.21%
66.21%
66.21%
66.21%
66.27%
66.26%
66.26%
66.26%
66.26%
DII
15.82%
15.98%
16.02%
14.7%
14.91%
16.01%
17.49%
17.41%
17.1%
17.02%
17.48%
17.5%
FII
0%
0%
0%
0%
0%
0%
8.54%
8.36%
9.11%
9.26%
8.86%
8.86%
Government
0%
0%
0%
0%
0%
0%
0%
0.01%
0.01%
0.01%
0.01%
0.01%
Public
8%
7.91%
7.74%
7.78%
8.2%
8.01%
7.76%
7.94%
7.52%
7.45%
7.39%
7.38%
Total Outstanding Shares
12,81,25,155
12,81,25,155
12,59,14,655
12,59,15,655
12,59,15,655
12,59,15,655
12,59,15,655
12,48,87,774
12,49,12,099
12,49,12,099
12,49,12,099
12,49,12,099
Total Shareholders
59,798
83,549
56,939
54,874
56,277
54,351
55,488
70,316
64,315
66,896
70,827
68,882

Mutual Funds that own Ajanta Pharma Ltd Stock

Check out the Mutual Funds with significant holdings in Ajanta Pharma Ltd.

Ajanta Pharma Ltd Earnings and Dividends

View detailed summary of the earnings and dividend history of Ajanta Pharma Ltd.

  • Ajanta Pharma Ltd Earnings Results

    Ajanta Pharma Ltd’s net profit jumped 3.89% since last year same period to ₹255.34Cr in the Q1 2025-2026. On a quarterly growth basis, Ajanta Pharma Ltd has generated 13.35% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Ajanta Pharma Ltd Dividends October,2024

    In the quarter ending September 2024, Ajanta Pharma Ltd has declared dividend of ₹28.00 per share on 28 Oct 2024 - translating a dividend yield of 2.11%.

    Read More about Dividends

Indices Featuring Ajanta Pharma Ltd Stock

Check stock indices that include Ajanta Pharma Ltd.

Nifty Midcap 150

₹21,898.80

0.31 (▲67.75%)

BSE Mid-Cap

₹46,909.03

0.36 (▲167.01%)

S&P BSE 150 MidCap

₹16,377.28

0.29 (▲46.94%)

BSE Healthcare

₹45,130.04

0.87 (▲391.31%)

Nifty MidSmallcap 400

₹20,322.20

0.22 (▲45.05%)

S&P BSE 400 MidSmallCap

₹12,313.95

0.18 (▲22.35%)

Nifty 500

₹23,518.90

0.31 (▲73.7%)

NIFTY PHARMA

₹22,574.35

1.5 (▲333%)

Nifty LargeMidcap 250

₹16,520.10

0.33 (▲54.5%)

BSE 500

₹36,930.41

0.32 (▲117.28%)

S&P BSE 250 LargeMidCap

₹10,971.22

0.36 (▲38.88%)

Insights on Ajanta Pharma Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 3 quarters, 1.17K Cr → 1.32K Cr (in ₹), with an average increase of 5.8% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, 225.26 Cr → 255.34 Cr (in ₹), with an average increase of 11.8% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 139.7% return, outperforming this stock by 37.6%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 66.26% of holdings in Jun 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 10.7% return, outperforming this stock by 28.6%

  • imgNO EFFECT

    FII Holding Unchanged

    img

    Foreign Institutions holdings remained unchanged at 8.86% of holdings in Jun 2025 quarter

  • imgNEGATIVE IMPACT

    MF Holding Down

    img

    Mutual Funds have decreased holdings from 15.13% to 14.72% in Jun 2025 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, AJANTPHARM stock has moved down by -4.8%

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 7.39% to 7.38% in Jun 2025 quarter

About Ajanta Pharma Ltd

Ajanta Pharma is a specialty pharmaceutical company with a wide range of products spanning across 30 countries. It works across therapeutic segments including AntiBiotic AntiMalarial AntiDiabetic Cardiology Gynecology Orthopedics Pediatric Respiratory and General Health products. Founded in 1973, it is headquartered in Mumbai India and has a mission of Serving Global Health Care Needs Worldwide. In their 47 years of operations, they have grown their operations by adding 7 state-of-the-art manufacturing facilities, 2 in India approved by the United States Food and Drug Administration (USFDA). Their Research & Development Centre in Mumbai has a team of over 750 scientists working on innovative products that are supplied to various government bodies in India, the US market and WHO approved programmes in Africa. The company also has 6 subsidiaries and 1 step-down subsidiary worldwide with investments in capex growing from Rs 997 crore to Rs 1225 crore. In addition, the company also has undertaken buybacks of 769230 equity shares in March 2019 and 735000 equity shares in November 2020. 16 new products were launched in FY2022, including 4 1st to market products in the country, 3 new products were launched with 8 ANDAs being filed and receiving 2 final and 1 tentative approval with 20 more pending approval from the USFDA.

Revenue: ₹1,302.65Cr as on June 2025 (Q1 FY26)
Net Profit: ₹255.34Cr as on June 2025 (Q1 FY26)
Listing date: 29 May, 2000
Chairperson Name: Mannalal B Agrawal
OrganisationAjanta Pharma Ltd
IndustryPharmaceuticals
CEOMannalal B Agrawal
E-voting on sharesClick here to vote

FAQs

What is Ajanta Pharma Ltd share price today?

Ajanta Pharma Ltd share price today stands at ₹2548.4 as on at the close of the market. Ajanta Pharma Ltd share today touched a day high of ₹2566 and a low of ₹2542.

What is the 52 week high and 52 week low range for Ajanta Pharma Ltd share?

Ajanta Pharma Ltd touched a 52 week high of ₹3428 and a 52 week low of ₹2327.3. Ajanta Pharma Ltd share price today i.e. is closed at ₹2548.4, which is -25.66% down from its 52 week high and 9.50% up from its 52 week low.

What is Ajanta Pharma Ltd's market capitalisation today?

Ajanta Pharma Ltd market capitalisation is ₹31,994.76 Cr as on .

How to buy Ajanta Pharma Ltd shares?

To buy Ajanta Pharma Ltd shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for AJANTPHARM or Ajanta Pharma Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Ajanta Pharma Ltd shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Ajanta Pharma Ltd trading volume today?

Ajanta Pharma Ltd trading volume is 45.62K as on . This means that 45.62K shares of Ajanta Pharma Ltd were bought and sold on the stock market during today's trading session.